Cumulative effects of ciprofloxacin and pilocarpine on cytotoxicity and G0 phase arrest in hepatoma-derived Hep G2 cell line.


Journal

The Journal of pharmacy and pharmacology
ISSN: 2042-7158
Titre abrégé: J Pharm Pharmacol
Pays: England
ID NLM: 0376363

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 12 02 2020
accepted: 23 05 2020
pubmed: 23 6 2020
medline: 23 6 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Uncontrolled cell proliferation was caused by multiple deficient pathways that inhibition of one pathway may result to activate an alternative pathway. Therefore, combination of drugs which targeted multiple pathways could be beneficial to overcome drug resistance. Ciprofloxacin (CPF) cytotoxicity was widely investigated on cancer cell lines, and results revealed hepatoma-derived Hep G2 cells are relatively resistant. So, this study aimed to increase CPF cytotoxicity by rational design of a supplement which targeted Ca Cells were treated by CPF and/or pilocarpine (PILO), and cell cycle distribution, caspases activity and regulatory proteins were evaluated. MTT and flow cytometry analysis confirmed administration of CPF + PILO causes more cytotoxicity. CPF-exposed cells accumulated in S phase due to DNA damages while PILO + CPF imposed G0 stage arrest through cyclin D1 and P-Akt downregulation. Caspase 8 was activated in cells treated by CPF but accompaniment of PILO with CPF led to activation of caspase 9, 8 and 3 and ROS overproduction. Ciprofloxacin imposed mitochondrial-independent apoptosis while PILO + CPF caused mitochondrial-dependent and independent apoptosis simultaneously. Consequently, coadministration of PILO and CPF causes intense cytotoxic effects through targeting the mitochondria, DNA gyrase enzyme and other unknown mechanisms.

Identifiants

pubmed: 32567066
doi: 10.1111/jphp.13318
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cytotoxins 0
Drug Combinations 0
Muscarinic Agonists 0
Pilocarpine 01MI4Q9DI3
Ciprofloxacin 5E8K9I0O4U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1383-1393

Subventions

Organisme : University of Tabriz

Informations de copyright

© 2020 Royal Pharmaceutical Society.

Références

Koziel R et al. Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells. J Physiol Pharmcol 2010; 61: 233-239.
Burden DA, Osheroff N. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1998; 1400: 139-154.
Zandi A et al. Evaluation of the cytotoxic effects of ciprofloxacin on human glioblastoma A-172 cell line. Middle East J Cancer 2017; 8: 119-126.
Smart DJ et al. Ciprofloxacin-induced G2 arrest and apoptosis in TH6 lymphoblastoid cells is not dependent on DNA double-strand break formation. Cancer Biol Ther 2008; 7: 113-119.
Aranha O et al. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res 2000; 6: 891-900.
Harbeck N et al. Breast cancer. Nat Rev Dis Primers 2019; 5: 66.
Mansoori B et al. The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 2017; 3: 339-348.
Herold C et al. Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 2002; 86: 443-448.
Wyrsch P et al. Cytosolic Ca2+ shifts as early markers of cytotoxicity. Cell Commun Signal 2013; 11: 11.
Zhu G, Lee AS. Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis. J Cell Physiol 2015; 230: 1413-1420.
Cerella C et al. The dual role of calcium as messenger and stressor in cell damage, death, and survival. Int J Cell Biol 2010; 2010: 546163.
Pronin AN et al. Teaching an old drug new tricks: agonism, antagonism, and biased signaling of pilocarpine through M3 muscarinic acetylcholine receptor. Mol Pharmacol 2017; 92: 601-612.
Zhou W et al. Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons. Cell Mol Neurobiol 2008; 28: 263-275.
Li JH et al. Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice. Diabetes 2009; 58: 2776-2787.
Sadeghi L et al. In vitro toxicity of iron oxide nanoparticle: oxidative damages on Hep G2 cells. Exp Toxicol Pathol 2015; 67: 197-203.
Yuan XL et al. Cytotoxicity of pilocarpine to human corneal stromal cells and its underlying cytotoxic mechanisms. Int J Ophthalmol 2016; 9: 505-511.
Zhu YY et al. Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells. Mol Med Rep 2015; 12: 5012-5018.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 1976; 72: 248-254.
Rezaei PF et al. Induction of G1 cell cycle arrest and cyclin D1 downregulation in response to pericarp extract of Baneh in human breast cancer T47D cells. DARU J Pharm Sci 2012; 20: 101.
Pilch DR et al. Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem Cell Biol 2003; 8: 123-129.
Vermes I et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.
Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 2000; 45: 528-537.
Goswami M et al. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother 2006; 50: 949-954.
Görlach A et al. Calcium and ROS: a mutual interplay. Redox Biol 2015; 6: 260-271.
Sadowski-Debbing K et al. Caspases-their role in apoptosis and other physiological processes as revealed by knock-out studies. Arch Immunol Ther Exp (Warsz) 2002; 50: 19-34.
Li P et al. Caspase-9: structure, mechanisms and clinical application. Oncotarget 2017; 8: 23996-24008.
Kominami K et al. The molecular mechanism of apoptosis upon caspase-8 activation: quantitative experimental validation of a mathematical model. Biochim Biophys Acta 2012; 1823: 1825-1840.
Renault TT et al. BAK/BAX activation and cytochrome c release assays using isolated mitochondria. Methods 2013; 61: 146-155.
Fatrai S et al. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 2006; 55: 318-325.
West JB et al. Multidrug cancer therapy in metastatic castrate-resistant prostate cancer: an evolution-based strategy. Clin Cancer Res 2019; 25: 4413-4421.
Antico Arciuch VG et al. Mitochondrial regulation of cell cycle and proliferation. Antioxid Redox Signal 2012; 16: 1150-1180.
Farfariello V et al. Calcium homeostasis in cancer: a focus on senescence. Biochim Biophys Acta 2015; 1853: 1974-1979.
De Zio D et al. New insights into the link between DNA damage and apoptosis. Antioxid Redox Signal 2013; 19: 559-571.
Yamaguchi H, Wang HG. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001; 20: 7779-7786.
Maddika S et al. Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. J Cell Sci 2008; 121: 979-988.
Du Z et al. Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4. J Biol Chem 2013; 288: 26678-26687.
Colomer J et al. Calmodulin regulates the expression of cdks, cyclins and replicative enzymes during proliferative activation of human T lymphocytes. Biochem Biophys Res Commun 1994; 200: 306-312.

Auteurs

Leila Sadeghi (L)

Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Somaiyeh Maleki (S)

Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Gholamreza Dehghan (G)

Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH